Fernwood Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.11M | Sell |
12,037
-775
| -6% | -$69.8K | 0.39% | 59 |
|
|
2024
Q3 | $1.07M | Sell |
12,812
-1,850
| -13% | -$141K | 0.35% | 68 |
|
|
2024
Q2 | $1.01M | Sell |
14,662
-500
| -3% | -$33.4K | 0.31% | 76 |
|
|
2024
Q1 | $1.11M | Sell |
15,162
-3,855
| -20% | -$296K | 0.32% | 74 |
|
|
2023
Q4 | $1.54M | Sell |
19,017
-1,175
| -6% | -$91.4K | 0.51% | 55 |
|
|
2023
Q3 | $1.51M | Sell |
20,192
-575
| -3% | -$44.2K | 0.54% | 52 |
|
|
2023
Q2 | $1.6M | Sell |
20,767
-1,600
| -7% | -$128K | 0.57% | 49 |
|
|
2023
Q1 | $1.86M | Sell |
22,367
-600
| -3% | -$49.7K | 0.71% | 41 |
|
|
2022
Q4 | $1.97M | Hold |
22,967
| – | – | 0.82% | 31 |
|
|
2022
Q3 | $1.42M | Sell |
22,967
-2,850
| -11% | -$180K | 0.6% | 50 |
|
|
2022
Q2 | $1.6M | Sell |
25,817
-4,300
| -14% | -$266K | 0.69% | 43 |
|
|
2022
Q1 | $1.79M | Sell |
30,117
-1,330
| -4% | -$85K | 0.63% | 44 |
|
|
2021
Q4 | $2.28M | Sell |
31,447
-1,090
| -3% | -$75.1K | 0.75% | 35 |
|
|
2021
Q3 | $2.27M | Sell |
32,537
-2,740
| -8% | -$192K | 0.78% | 37 |
|
|
2021
Q2 | $2.43M | Sell |
35,277
-525
| -1% | -$35.1K | 0.8% | 37 |
|
|
2021
Q1 | $2.31M | Sell |
35,802
-500
| -1% | -$32.2K | 0.85% | 35 |
|
|
2020
Q4 | $2.12M | Sell |
36,302
-350
| -1% | -$21.1K | 0.83% | 34 |
|
|
2020
Q3 | $2.32M | Sell |
36,652
-3,325
| -8% | -$231K | 1.09% | 25 |
|
|
2020
Q2 | $3.08M | Sell |
39,977
-3,275
| -8% | -$251K | 1.52% | 15 |
|
|
2020
Q1 | $3.23M | Sell |
43,252
-1,308
| -3% | -$90.4K | 2.06% | 10 |
|
|
2019
Q4 | $2.9M | Sell |
44,560
-755
| -2% | -$49.2K | 1.39% | 17 |
|
|
2019
Q3 | $2.87M | Buy |
45,315
+3,446
| +8% | +$225K | 1.42% | 13 |
|
|
2019
Q2 | $2.83M | Sell |
41,869
-2,253
| -5% | -$148K | 1.55% | 11 |
|
|
2019
Q1 | $2.87M | Sell |
44,122
-478
| -1% | -$31.8K | 1.53% | 10 |
|
|
2018
Q4 | $2.79M | Buy |
44,600
+601
| +1% | +$42K | 1.8% | 9 |
|
|
2018
Q3 | $3.4M | Sell |
43,999
-1,299
| -3% | -$98.1K | 1.8% | 8 |
|
|
2018
Q2 | $3.21M | Sell |
45,298
-1,345
| -3% | -$95K | 1.73% | 9 |
|
|
2018
Q1 | $3.52M | Sell |
46,643
-2,600
| -5% | -$207K | 1.96% | 7 |
|
|
2017
Q4 | $3.53M | Sell |
49,243
-2,790
| -5% | -$212K | 1.89% | 8 |
|
|
2017
Q3 | $4.22M | Buy |
52,033
+899
| +2% | +$68.7K | 2.64% | 5 |
|
|
2017
Q2 | $3.62M | Buy |
51,134
+600
| +1% | +$39.9K | 2.63% | 6 |
|
|
2017
Q1 | $3.43M | Sell |
50,534
-470
| -0.9% | -$33K | 2.73% | 6 |
|
|
2016
Q4 | $3.65M | Buy |
51,004
+1,103
| +2% | +$82K | 3.5% | 4 |
|
|
2016
Q3 | $3.95M | Buy |
49,901
+1,400
| +3% | +$114K | 3.62% | 3 |
|
|
2016
Q2 | $4.05M | Buy |
48,501
+220
| +0.5% | +$19.5K | 3.96% | 4 |
|
|
2016
Q1 | $4.43M | Sell |
48,281
-10,550
| -18% | -$951K | 4.49% | 2 |
|
|
2015
Q4 | $5.95M | Buy |
58,831
+322
| +0.6% | +$33.5K | 5.09% | 2 |
|
|
2015
Q3 | $5.75M | Buy |
58,509
+755
| +1% | +$83.9K | 5.04% | 2 |
|
|
2015
Q2 | $6.76M | Buy |
57,754
+105
| +0.2% | +$11.5K | 5.31% | 2 |
|
|
2015
Q1 | $5.66M | Sell |
57,649
-250
| -0.4% | -$25.4K | 4.65% | 2 |
|
|
2014
Q4 | $5.46M | Buy |
57,899
+3,790
| +7% | +$392K | 4.64% | 2 |
|
|
2014
Q3 | $5.76M | Sell |
54,109
-1,090
| -2% | -$107K | 4.96% | 2 |
|
|
2014
Q2 | $4.58M | Buy |
55,199
+3,990
| +8% | +$311K | 3.78% | 2 |
|
|
2014
Q1 | $3.63M | Sell |
51,209
-17,675
| -26% | -$1.39M | 3.37% | 2 |
|
|
2013
Q4 | $5.17M | Buy |
+68,884
| New | +$4.8M | 3.44% | 2 |
|
Other funds holding GILD
Fernwood Investment Management's GILD Position: Q4 2024 in Review
Fernwood Investment Management reduced its Gilead Sciences (GILD) stake by 6% in Q4 2024, selling an estimated $69.8K and leaving 12,037 shares worth $1.11M. The position accounts for 0.39% of the portfolio, ranked #59.
Fernwood Investment Management first reported a position in GILD in Q4 2013 and has held it in 45 quarters since. The position peaked at $6.76M in Q2 2015. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Fernwood Investment Management held 12,037 shares of Gilead Sciences worth $1.11M as of Q4 2024.
- Fernwood Investment Management sold 775 Gilead Sciences shares in Q4 2024, an estimated $69.8K.
- Gilead Sciences made up 0.39% of Fernwood Investment Management's portfolio in Q4 2024, its #59 holding.
- Fernwood Investment Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 45 quarters since.
- Fernwood Investment Management's Gilead Sciences position peaked at $6.76M in Q2 2015.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.